Trial intelligence / Profile preview

Effect of human chorionic gonadotropin and embryo glue in infertility

IRCT20221126056614N1Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Dec 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of human chorionic gonadotropin in infertility, sponsored by Mazandaran University of Medical Sciences. Started Dec 2022; status: completed.

02

Drugs

human chorionic gonadotropin
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT20221126056614N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221126056614N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call